The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of the scientific sessions for its 19th Annual European Congress that will begin next week, 29 October-2 November 2016 in Vienna, Austria.
ISPOR announced the publication of a report in the September/October issue of Value in Health detailing a new modeling approach that explores the health technology assessment impact of future medical-technology price reductions that are caused by increased adoption and use of these technologies.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has published a new report, “Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report,” in the September/October 2016 issue of Value in Health.
ISPOR held its Initiative on US Value Assessment Frameworks Stakeholder Conference, in Washington, DC, USA on September 23, 2016. The meeting was designed to convene stakeholders across all segments of health care to generate input and help guide the scope of work for the Initiative’s Special Task Force.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 19th Annual European Congress that will be held 29 October–2 November 2016 in Vienna, Austria.
The third plenary session for ISPOR’s 7th Asia-Pacific Conference—The Affordable Dream in ASEAN: Experiences and Lessons Learned—was held this morning in Singapore.
The second plenary session for the the ISPOR 7th Asia-Pacific Conference—Harnessing the Power of Big Data to Make Better Health Care Decisions in the Asia-Pacific Region—was held this morning in Singapore.
ISPORis first plenary session for the Society’s 7th Asia-Pacific Conference—Health Technology Assessment and Health Policy: Recent Developments Across Asia—was held this afternoon in Suntec City, Singapore.
ISPOR's Medical Devices and Diagnostics Special Interest Group report, “Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations,” was published in the July/August 2016 issue (Volume 19, Issue 5) of Value in Health.
ISPOR announced today the publication of a series of articles suggesting that the application of cost-effectiveness analysis for health care decision making in the US may be approaching critical mass. This special themed section was published in the July/August 2016 in Value in Health.
ISPOR announced confirmation of key scientific sessions for its 7th Asia-Pacific Conference scheduled to begin next week, 3-6 September 2016 in Singapore.
ISPOR announced that it is holding a Stakeholder Conference for its Initiative on US Value Assessment Frameworks on September 23 in Washington, DC, USA.
ISPOR announced that its Chief Executive Officer Nancy Berg has been named a 2016 PharmaVOICE 100.
ISPOR announced the publication of a study comparing the metrics obtained from profile-case best-worst scaling (BWS) with those from a discrete choice experiment (DCE) with respect to hip replacement surgery. The study was published in the June 2016 issue of Value in Health.
ISPOR announced today that it will be holding a two-day training program on budget impact analysis, Building a Budget Impact Model: Budget Impact Analysis Training, in Durham, NC, USA on November 16-17, 2016.
ISPOR announced the election of the Society’s 2016-2017 Board of Directors that assumed office on July 1, 2016.
ISPOR announced today the publication of an empirical study demonstrating that current Medicaid policies restricting hepatitis C treatment to patients with advanced disease are more costly and less effective than unrestricted, full-access strategies.
ISPOR has published its third Good Research Practices Task Force Report on preference-based methods that measure patient and other stakeholder preferences. The report appears in the June 2016 issue (Volume 19, Issue 4) of Value in Health.
New data released by Thomson Reuters' Journal Citation Reports show that Value in Health is ranked as one of the top journals in the health policy and sciences category, ranking 3rd among 74 journals in the field. . This year's data show that Value in Health's impact factor score has increased by 16.6% to 3.824. This is the third year in a row that the journal has shown double-digit growth in the percentage of improvement in its impact factor score.
ISPOR announced its plenary sessions and speakers for its 7th Asia-Pacific Conference that will be held 3-6 September 2016 in Singapore. The plenary sessions will explore concepts related to the conference theme—Pharmacoeconomics and Outcomes Research in Asia-Pacific: Challenges, Opportunities, and Future Direction.
ISPOR's 21st Annual International Meeting recently concluded in Washington, DC, USA. Government officials, health ministries, and global thought leaders in health economics and outcomes research (HEOR) from more than 80 countries convened in the US capital during an election year on May 21–25, 2016.
ISPOR announced today that CEO and Executive Director Nancy Berg has been recognized as a transformational leader by PM360’s annual ELITE award program.
The third plenary session for ISPOR's 21st Annual International Meeting—Contemporary Regulatory and Legislative Issues in Health Outcomes Research—was held this morning in Washington, DC, USA.
The ISPOR 21st Annual International Meeting Workshop 23—Methodologies for Evaluating Geospatial Access in Medication Use Studies—was held this afternoon in Washington, DC, USA.
The ISPOR 21st Annual International Meeting Issue Panel 20—What Is the Value of Frameworks to Patients? The Case in Oncology—was held this morning in Washington, DC, USA.
The ISPOR 21st Annual International Meeting Issue Panel 18—Precision Medicine: The End of Outcomes Research?—was held this morning in Washington, DC, USA.
The ISPOR 21st Annual International Meeting Workshop 13—Patients as Partners in Research—Making It a Reality—was held this afternoon in Washington, DC, USA.
ISPOR's 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon in Washington, DC, USA.
The second ISPOR plenary session on Making Medical Decisions in an Irrational World was held this morning at the Society’s 21st Annual International Meeting in Washington, DC, USA.
ISPOR recognized its 2016 Awards Program recipients at the 21st Annual International Meeting in Washington, DC, USA. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR).
ISPOR 21st Annual International Meeting Workshop 2—Risk-Sharing Agreements for Manufacturers and Commercial Payers in the United States: How Can Theory Help Practice? Design and Aligning Incentives Are Key—was held this afternoon in Washington, DC, USA.
ISPOR 21st Annual International Meeting Issue Panel 5—Use of Real-Word Evidence in Payer Decision Making: Fact or Fiction?—was held this morning in Washington, DC, USA.
ISPOR opened its 21st Annual International Meeting this morning with the first plenary session, Accelerating Cures: Addressing Unmet Patient Need or Putting Patients at Risk?, in Washington, DC, USA.
ISPOR announced confirmation of key scientific sessions for its 21st Annual International Meeting starting next week, May 21-25, 2016 in Washington, DC, USA. The meeting will feature three, timely Plenary Sessions centered on the theme, “Value, Affordability, and Patient Centeredness: Can We Have It All?”.
ISPOR announced today that it has published a new Global Health Care Systems Road Map—Australia Medical Devices.
ISPOR announced today that it is expanding its leadership team with the appointment of Richard J. Willke, PhD as Chief Science Officer for the organization.
ISPOR announced today the launch of its new interactive job board, the ISPOR Career Center. With its global focus on health economics and outcomes research (HEOR), the ISPOR Career Center offers job seekers and organizations seeking candidates with HEOR expertise an easy-to-use and highly targeted resource for online employment connections.
ISPOR published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force, ” in the March/April 2016 issue of Value in Health.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its next Health Technology Assessment (HTA) Training Program will be held in Lisbon, Portugal from 26-29 June 2016.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the recipients of its 2016 Scientific Achievement Awards. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in HEOR.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its candidates today for open positions on the 2016–2017 Board of Director.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its three plenary sessions and speakers for the 21st Annual International Meeting that will be held May 21–25, 2016 in Washington, DC, USA. Each of the three plenary sessions will explore the concepts of the conference theme—Value, Affordability, and Patient Centeredness: Can We Have It All?.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force,” in the January/February 2016 issue of Value in Health (Volume 19, Issue 1).
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its Latin America Consortium Publications Committee has published its first Science Policy Brief—Budget Impact Analysis: New Norms (El Análisis del Impacto Presupuestario: Nuevas Normas).
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it has published a new Global Health Care Systems Road Map—Denmark Pharmaceuticals. ISPOR Global Health Care Systems Road Maps provide an overview of country-specific, health care delivery systems.
ISPOR announced today a new Student Network benefit that now provides ISPOR student members with complimentary access to FormularyDecisions.com®.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress recently concluded in Milan, Italy. Health ministries and government officials from more than 40 countries convened in Milan on 7-11 November, 2015 with over 5,000 ISPOR delegates.
ISPOR recognized its 2015 ISPOR Award recipients at the 18th Annual European Congress in Milan, Italy.
ISPOR's 18th Annual European Congress third plenary session — Recommendations from the ISPOR Multi-Criteria Decision Analysis Emerging Good Practice Task Force and Remaining Controversies — was held this morning at the MiCo – Milano Congressi in Milan, Italy.
ISPOR 18th Annual European Congress Workshop 12 focused on the issue of, “Optimizing Patient Involvement in Payer Health Care Decisions to Access New Therapies.”
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right